HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety, tolerability, and pharmacokinetics of KNS-760704 (dexpramipexole) in healthy adult subjects.

Abstract
Dexpramipexole (KNS-760704; [6R]-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine) is a novel synthetic amino-benzothiazole in development for the treatment of amyotrophic lateral sclerosis (ALS). Preclinical studies have shown that dexpramipexole is neuroprotective in vitro and in vivo, is highly orally bioavailable and water soluble, and rapidly achieves and maintains high central nervous system concentrations relative to plasma. Two phase 1 clinical studies were conducted to assess the safety, tolerability, and pharmacokinetics (PK) of single and multiple doses of dexpramipexole in 54 healthy male and female adults. The effect of food on the single-dose PK of dexpramipexole was also evaluated. Single doses (50 mg, 150 mg, or 300 mg) and multiple doses (50 mg twice daily, 100 mg twice daily, or 150 mg twice daily) of dexpramipexole over 4.5 days were safe and well tolerated. Dexpramipexole was rapidly absorbed, with time to maximum plasma concentration ranging from 1.8 to 2.6 hours and half-life ranging from 6.4 to 8.1 hours under fasted conditions, and was mostly eliminated in urine as unchanged parent drug (84%-90% of dose). Food had no effect on the single-dose PK of dexpramipexole. These findings support the ongoing development of dexpramipexole for the treatment of ALS and further evaluation of the compound's therapeutic potential in other neurodegenerative diseases.
AuthorsMichael E Bozik, James L Mather, William G Kramer, Valentin K Gribkoff, Evan W Ingersoll
JournalJournal of clinical pharmacology (J Clin Pharmacol) Vol. 51 Issue 8 Pg. 1177-85 (Aug 2011) ISSN: 1552-4604 [Electronic] England
PMID20959524 (Publication Type: Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial)
Chemical References
  • Benzothiazoles
  • Dopamine Agonists
  • Drugs, Investigational
  • Pramipexole
Topics
  • Adult
  • Benzothiazoles (administration & dosage, adverse effects, analysis, pharmacokinetics)
  • Dopamine Agonists (administration & dosage, adverse effects, analysis, pharmacokinetics)
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drugs, Investigational (administration & dosage, adverse effects, analysis, pharmacokinetics)
  • Female
  • Food-Drug Interactions
  • Half-Life
  • Humans
  • Intestinal Absorption
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Plasma (chemistry)
  • Pramipexole
  • Urine (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: